Zhu Chang-kun, Ye Da-feng, Xie Xing, Cheng Xiao-dong, Chen Huai-zeng, Lu Wei-guo
Department of Oncology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou 310006, China.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Aug;25(4):422-6.
In this study, we assayed promoter hypermethylation and protein expression of the mismatch repair gene (MMR) hMLH1 and hMSH2 in gestational trophoblastic diseases to understand the significance of MMR promoter methylation and expression in the pathogenesis and malignant transformation of hydatidiform mole.
DNA was extracted from chorion of early pregnancies, partial hydatidiform moles, complete hydatidiform moles, and invasive moles were over digested by methylation sensitive endonuclease Hpa II. Then the promoters were amplificated by polymerase chain reaction. The protein was detected by immunohistochemistry.
In the normal placenta, neither hMLH1 nor hMSH2 promoter methylation was detected. Expression of hMLH1 and hMSH2 in cytotrophoblasts was strongly positive, and that was negative or weakly positive in syncytiotrophobasts. In all normal chorion, expression of hMLH1 and hMSH2 in cytotrophoblasts was strongly positive. In partial hydatidiform mole and complete hydatidiform mole, the methylation of hMLH1 and hMSH2 promoters was significantly higher than that of early placenta (P < 0.05), and the protein expression in cytotrophoblasts was significantly lower (P < 0.05). In the invasive mole, hMLH1 and hMSH2 promoter methylation were not significantly different as compared with the partial hydatidiform mole and complete hydatidiform mole (P > 0.05). Expression of hMLH1 in the invasive mole (54.5%, 6/11) was not significantly different as compared with the partial hydatidiform mole and complete hydatidiform mole (P > 0.05). But expression of hMSH2 in the invasive mole (36.4%, 4/11) was weaker than that in complete hydatidiform mole (P = 0.044). Promoter methylation and less expression of hMSH2 had correlations in complete hydatidiform mole or invasive mole.
Strong expressions of hMLH1 and hMSH2 in the cytotrophoblasts of normal placenta may keep the genome stability. Promoter methylation and down-regulation of hMLH1 and hMSH2 are probably involved in the pathogenesis of hydatidiform mole.
在本研究中,我们检测了妊娠滋养细胞疾病中错配修复基因(MMR)hMLH1和hMSH2的启动子高甲基化及蛋白表达情况,以了解MMR启动子甲基化及表达在葡萄胎发病机制及恶变中的意义。
从早孕绒毛、部分性葡萄胎、完全性葡萄胎及侵蚀性葡萄胎中提取DNA,用甲基化敏感内切酶Hpa II进行过度消化。然后通过聚合酶链反应扩增启动子。用免疫组织化学法检测蛋白。
在正常胎盘中,未检测到hMLH1和hMSH2启动子甲基化。细胞滋养层细胞中hMLH1和hMSH2表达呈强阳性,而合体滋养层细胞中呈阴性或弱阳性。在所有正常绒毛中,细胞滋养层细胞中hMLH1和hMSH2表达呈强阳性。在部分性葡萄胎和完全性葡萄胎中,hMLH1和hMSH2启动子甲基化显著高于早孕胎盘(P<0.05),细胞滋养层细胞中蛋白表达显著降低(P<0.05)。在侵蚀性葡萄胎中,hMLH1和hMSH2启动子甲基化与部分性葡萄胎和完全性葡萄胎相比无显著差异(P>0.05)。侵蚀性葡萄胎中hMLH1的表达(54.5%,6/11)与部分性葡萄胎和完全性葡萄胎相比无显著差异(P>0.05)。但侵蚀性葡萄胎中hMSH2的表达(36.4%,4/11)低于完全性葡萄胎(P=0.044)。在完全性葡萄胎或侵蚀性葡萄胎中,hMSH2启动子甲基化与表达降低存在相关性。
正常胎盘细胞滋养层细胞中hMLH1和hMSH2的强表达可能维持基因组稳定性。hMLH1和hMSH2的启动子甲基化及下调可能参与葡萄胎的发病机制。